Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoli Yang

Showing results (591-600 of 607) with videos related to

Pageof 61
Sort By:
Journal of Virology|September 22, 2021
Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse ModelShi Zou, Yanqin Du, Shunmei Huang, et al.
BMC Medicine|July 19, 2023
Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolitesDeyu Zhang, Siyuan Weng, Chuanchao Xia, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2026
Automated Chest X-ray Report Generation Remains UnsolvedXiaoman Zhang, Julian Nicolas Acosta, Xiaoli Yang, et al.
Nature Chemical Biology|August 26, 2025
Oncometabolite 5-IP<sub>7</sub> inhibits inositol 5-phosphatase to license E-cadherin endocytosisHongyun Zhang, Bobo Zhang, Yuebo Zhao, et al.
Journal of Molecular Endocrinology|November 17, 2022
GP73 blockade alleviates abnormal glucose homeostasis in diabetic miceXiaopan Yang, Xiaojing Fan, Jiangyue Feng, et al.
Scientific Reports|January 14, 2023
Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulationsKatharina Köchl, Tobias Schopper, Vedat Durmaz, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacyJialong Liu, Chao Feng, Ruzhou Zhao, et al.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Nature Communications|March 23, 2021
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19Jun Wu, Boyun Liang, Cunrong Chen, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
Pageof 61

Showing results (591-600 of 607) with videos related to

Sort By:
Pageof 61
Journal of Virology|September 22, 2021
Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse ModelShi Zou, Yanqin Du, Shunmei Huang, et al.
BMC Medicine|July 19, 2023
Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolitesDeyu Zhang, Siyuan Weng, Chuanchao Xia, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2026
Automated Chest X-ray Report Generation Remains UnsolvedXiaoman Zhang, Julian Nicolas Acosta, Xiaoli Yang, et al.
Nature Chemical Biology|August 26, 2025
Oncometabolite 5-IP<sub>7</sub> inhibits inositol 5-phosphatase to license E-cadherin endocytosisHongyun Zhang, Bobo Zhang, Yuebo Zhao, et al.
Journal of Molecular Endocrinology|November 17, 2022
GP73 blockade alleviates abnormal glucose homeostasis in diabetic miceXiaopan Yang, Xiaojing Fan, Jiangyue Feng, et al.
Scientific Reports|January 14, 2023
Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulationsKatharina Köchl, Tobias Schopper, Vedat Durmaz, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacyJialong Liu, Chao Feng, Ruzhou Zhao, et al.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Nature Communications|March 23, 2021
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19Jun Wu, Boyun Liang, Cunrong Chen, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
Pageof 61